Xuhua Duan
Clinical trials sponsored by Xuhua Duan, explained in plain language.
-
New combo attack on tough liver cancer
Disease control Not yet recruitingThis study is looking at a two-part treatment for liver cancer that cannot be removed by surgery. It combines a procedure that blocks the tumor's blood supply with tiny drug-filled beads, followed by a daily oral medication called Donafenib. The goal is to see if this approach is…
Sponsor: Xuhua Duan • Aim: Disease control
Last updated Apr 01, 2026 23:26 UTC
-
AI to predict side effects in liver cancer treatment
Knowledge-focused Not yet recruitingThis study aims to understand why liver cancer patients have different outcomes and side effects when receiving a combination of localized and drug-based treatments. Researchers will analyze real-world medical records from 2,000 patients to identify patterns. The goal is to build…
Sponsor: Xuhua Duan • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC